The Efficacy and Safety of Myelophil, an Ethanol Extract Mixture of Astragali Radix and Salviae Radix, for Chronic Fatigue Syndrome: A Randomized Clinical Trial.

Front Pharmacol · 2019 · PMC6746924 · PMID 31551788

Europe PMC DOI

hedged sentences

0.0690

closest p · 1.4× alpha

0.0690

boldest claim

The sentences

a distinct trend toward significancep = 0.069so close (0.05 < p ≤ 0.1)

The VAS was decreased in the Myelophil group compared with that in the placebo group, with a distinct trend toward significance (4.2 ± 2.5 vs . 2.8 ± 2.5, p = 0.069.

also in 9 other papers

a positive trendno p-value reported

In fact, the present study showed a positive trend in changes of TNF-α and IFN-γ with disease severity, but this was not statistically significant.

also in 11,005 other papers

a considerable trend toward significanceno p-value reported

In the analysis for VAS, there was a pattern of improvement with a considerable trend toward significance.

also in 24 other papers

did not reach statistical significanceno p-value reported

Myelophil administration for 12 weeks seemed to further improve the fatigue symptoms in CFS patients compared with the placebo; however, this difference did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.